#medic aid

[monako-jinn-stories]

It’s late, and I haven’t posted for a while, but happy pride month from me, you’re local Jinn, and Jawa Squad!🩷❤️🧡💛💚🩵💙💜🖤🩶🤍🤎

My personal identities include omnisexual and genderfluid!

I put each of my oc troopers from Jawa Squad’s flags on their respective helmets (bomber was killed before phase 2)

Flags in order,

Left side: Ally, Bisexual, Omnisexual

Right side: Aromantic-asexual, aromantic-asexual gay, gay

[neurotypicalabusesurvivor]

This is a friendly reminder that none disabled people often do benefit from the same accommodations disabled people benefit from.

[prokopetz]

A few tabletop RPG creators you might recognise from previous posts on this blog – myself included – are participating in this charity bundle benefiting Medical Aid for Palestinians. The beneficiary has been on-boarded with itch.io, and all proceeds go directly to them without passing through the organisers' hands.

[lrndvs]

Blood Moon Rising Now that the zine I was in has shipped, I can finally share my piece!

[c-u-c-koo-4-40k]

What should you bring to school?

For the people of Gaza, the memories of days spent in school are distant. But education is not Only a Right but a Duty.

Meet Anas and Ahmad, they are related to Osama Basil, who has his own gofundme.

While managing his own gfm, Osama is also trying to help Anas and Ahmed fund their education somewhere safe, away from the Turmoil in Gaza.

They are Bright Wonderful students who want to pursue careers in computer business and medicine!

Please give some time to this Verified campaign!

Current Funding

€4,870 / €29,000

~16% Funded

Tag List for Reach DM me for Removal

And to others putting me in mentions I am So Sorry I'm not getting to many of them, I'm trying to balance between DM campaigns, ask campaigns and the mentions I get each day.

@a-shade-of-blue @sunnylittledragon

@selflovejolteon @virovac

@frustrated-froglet @qattdraws @heydreamchild

@amvs @boosting-donations

@sweet-honey-bunnies

@dyspunktional-leviathan

@nobelgasxenon

@zone0neko

@comrademango

[vyorei]

Here's an amalgamation of news from the last 2 hours

Schools, hospitals, the one road civilians are fleeing down, NOTHING IS FUCKING SAFE.

WERE YOU ANGRY ABOUT AL-AHLI? WELL HERE, THERE'S FUCKING MORE. BRING THAT RAGE BACK AND START MAKING NOISE.

[myceliacrochet]

Teenager recovering from MAJOR SURGERY while UNDER IOF FIRE!!!

Donate: https://gofund.me/5da752c4

Moneer is a teenager who is recovering from a 4-hour surgery in Gaza, in the freezing December cold, during a forced mass starvation while dodging IOF bullets!!!

The IOF just slaughtered his uncle and his cousin, and they could kill the whole family at any moment.

His mom has asthma, which is wildly dangerous amid bombings and with no treatment. His 4yo sister is freezing and malnutritioned.

Give this empathetic teenager and his family hope!!!!

Donate: https://gofund.me/5da752c4

Vetted!!!! GazaVetters #8

@skaianbruja @bugnitesblog @mar64ds @fricklefracklefloof @unwinni3 @mloking @prodivorce @whateveroursoulsaremadeoff @hehemechief @cultreslut @halfbloodfanboy @pontaoski @elbiotipo @infoplaza @selkiebrides @localcoffeeaddict @keepinitwrd @bloodandgutsyippee @iqinitials @wherethatoldtraingoes2 @butchniqabi @appsa @frigidwife @vetted-gaza-funds @gazagfmboost @opencommunion @beserkerjewel @deepspaceboytoy @rhubarbspring @eryuditely @lesbianmaxevans @malcriada @turian @sxpph0 @rebel-girl-queen-of-my-world @neptunerings @dykesbat @halalgirlmeg @userpeggycarter @minosbull @hamstertross

[jackoshadows]

Ex-NHS surgeon Nizam Mamode broke down as he told the international development committee what he witnessed when working as a surgeon in Gaza.

Q: You believe it was deliberate targeting of civilians? A: Absolutely no question in my mind and I and it's been uh it's been the experience of so many healthcare workers who've documented it time and time and time again um but my personal experience and those of my colleagues was this was clearly persistent deliberate targeting of civilians and I've worked in a number of conflict zones um in different parts of the world I was there at the time of the Rwandan genocide um I've never seen anything on this scale ever and that was also the view of all the experienced colleagues that I worked with um one of the surgeons in my team had been to Ukraine five times and said this is 10 times worse normally in a conflict Zone you would have a front line have fighting going on between um two sets of forces and you might get some civilians injured in in that um in that exchange there doesn't seem to be a front line there just seems to be 1.4 million people trapped they can't leave and having bombs dropped on them on a daily basis and then drones coming in and shooting them and um and there's plenty of evidence um out there uh from from Israeli soldiers that that's what's going on but we saw it you know we saw the results of it

Dr. Mamode talks about how they are running out of supplies to operate and how they used the last of their shunts - device used to bypass artery in the neck to supply blood to the brain - on a three year old shot deliberately in the neck by an IDF drone. The 3 year old died 4 days later from infection because they don't have the medicines either.

Please donate:

[hiiragi7]

Here's some positivity towards people with medical devices that others view as "gross", or "shouldn't be seen in public". It's bullshit the way this gets treated and I want more positivity about it, so I'm making it myself.

People with catheters. People with stoma bags. People with feeding tubes. People who have tubing or medical alterations they can't hide. People who otherwise have medical devices which are deemed "not socially acceptable" and "gross".

Your medical devices deserve to take up space. We should not be made to feel ashamed for devices which keep us alive. We should not be made to feel insecure for the ways our bodies function and the assistance we need to live. You deserve to be yourself, you deserve to exist in public as a disabled person, and you deserve to be accepted and celebrated as yourself, medical devices included.

[classychassiss]

Responding to direct requests for aid from our contacts in the area, we are loading up a truck and heading north to support our fellow southerners this weekend. We need to make $2000 fast to cover the entire wishlist provided to us by folks in North Carolina. Can you help us? Cash-app and Venmo is @/TeamKombatikon. Donations can also be made through ko-fi.com/angelito

Thank you so much!

[monako-jinn-stories]

Hex: wake me up-

Sans: before you go go!

Aid: when september ends…

Steele: WAKE ME UP IN SIDE!!

[stellaltumi]

my chronically ill best friend just said "I feel like the side effects part of a medication commercial" SO FUCKING TRUE BABE

[a-scary-lack-of-common-sense]

BOO hey girlypops, I'm back

[reasonsforhope]

"A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection.

The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or PrEP) drugs.

Physician-scientist Linda-Gail Bekker, principal investigator for the South African part of the study, tells Nadine Dreyer what makes this breakthough so significant and what to expect next.

Tell us about the trial and what it set out to achieve

The Purpose 1 trial with 5,000 participants took place at three sites in Uganda and 25 sites in South Africa to test the efficacy of lenacapavir and two other drugs.

Lenacapavir (Len LA) is a fusion capside inhibitor. It interferes with the HIV capsid, a protein shell that protects HIV’s genetic material and enzymes needed for replication. It is administered just under the skin, once every six months.

The randomised controlled trial, sponsored by the drug developers Gilead Sciences, tested several things.

The first was whether a six-monthly injection of lenacapavir was safe and would provide better protection against HIV infection as PrEP for women between the ages of 16 and 25 years than Truvada F/TDF, a daily PrEP pill in wide use that has been available for more than a decade.

Secondly, the trial also tested whether Descovy F/TAF, a newer daily pill, was as effective as F/TDF...

The trial had three arms. Young women were randomly assigned to one of the arms in a 2:2:1 ratio (Len LA: F/TAF oral: F/TDF oral) in a double blinded fashion. This means neither the participants nor the researchers knew which treatment participants were receiving until the clinical trial was over.

In eastern and southern Africa, young women are the population who bear the brunt of new HIV infections. They also find a daily PrEP regimen challenging to maintain, for a number of social and structural reasons.

During the randomised phase of the trial none of the 2,134 women who received lenacapavir contracted HIV. There was 100 percent efficiency.

By comparison, 16 of the 1,068 women (or 1.5%) who took Truvada (F/TDF) and 39 of 2,136 (1.8%) who received Descovy (F/TAF) contracted the HIV virus...

What is the significance of these trials?

This breakthrough gives great hope that we have a proven, highly effective prevention tool to protect people from HIV.

There were 1.3 million new HIV infections globally in the past year. Although that’s fewer than the 2 million infections seen in 2010, it is clear that at this rate we are not going to meet the HIV new infection target that UNAIDS set for 2025 (fewer than 500,000 globally) or potentially even the goal to end Aids by 2030...

For young people, the daily decision to take a pill or use a condom or take a pill at the time of sexual intercourse can be very challenging.

HIV scientists and activists hope that young people may find that having to make this “prevention decision” only twice a year may reduce unpredictability and barriers.

For a young woman who struggles to get to an appointment at a clinic in a town or who can’t keep pills without facing stigma or violence, an injection just twice a year is the option that could keep her free of HIV.

What happens now?

The plan is that the Purpose 1 trial will go on but now in an “open label” phase. This means that study participants will be “unblinded”: they will be told whether they have been in the “injectable” or oral TDF or oral TAF groups.

They will be offered the choice of PrEP they would prefer as the trial continues.

A sister trial is also under way: Purpose 2 is being conducted in a number of regions including some sites in Africa among cisgender men, and transgender and nonbinary people who have sex with men.

It’s important to conduct trials among different groups because we have seen differences in effectiveness. Whether the sex is anal or vaginal is important and may have an impact on effectiveness.

How long until the drug is rolled out?

We have read in a Gilead Sciences press statement that within the next couple of months [from July 2024] the company will submit the dossier with all the results to a number of country regulators, particularly the Ugandan and South African regulators.

The World Health Organization will also review the data and may issue recommendations.

We hope then that this new drug will be adopted into WHO and country guidelines.

We also hope we may begin to see the drug being tested in more studies to understand better how to incorporate it into real world settings.

Price is a critical factor to ensure access and distribution in the public sector where it is badly needed.

Gilead Sciences has said it will offer licences to companies that make generic drugs, which is another critical way to get prices down.

In an ideal world, governments will be able to purchase this affordably and it will be offered to all who want it and need protection against HIV."

-via The Conversation, July 3, 2024